Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 2, 2019Diabetes Obesity and Metabolism

Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

ILIliana C. LegaToronto Public HealthSBSusan E. BronskillSunnybrook Health Science CentreMCMichael A. CampitelliInstitute for Clinical Evaluative Sciences

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lega et al. (2019) studied this question.

synapsesocial.com/papers/69d8bd54d2f7327e70ae4189https://doi.org/10.1111/dom.13820
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of SGLT2 inhibitors in a murine model of urinary tract infection with Candida albicans2014 · 22 citations
  2. 2Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes2018 · 166 citations
  3. 3Diabetes in Ontario2002 · 1,296 citations
  4. 4Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA2013 · 122 citations
  5. 5Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study2018 · 368 citations